Dr. Poorvu received his medical degree from the University of Pennsylvania in 2012 and went on to complete his residency in internal medicine at the Brigham and Women's Hospital. He is a medical oncologist in the Breast Oncology Center and has a particular interest in the care of young women with breast cancer and breast cancer survivorship. His research seeks to better understand the impact of cancer treatments on fertility and a number of other survivorship issues. Dr. Poorvu's research is also focused on the use of genomic risk prediction assays and predictive biomarkers to help guide the management of breast cancer patients. Dr. Poorvu is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Dr. Suniti N. Nimbkar is a surgeon at Brigham and Women’s Hospital (BWH) , the medical director for the Breast Care Center at South Shore Hospital, in clinical affiliation with the Dana-Farber Brigham Cancer Center, and an instructor in surgery at Harvard Medical School.Dr. Nimbkar received her medical degree from Boston University School of Medicine and then completed a surgery residency at Boston University Medical Center (now Boston Medical Center). She is board certified in general surgery.Dr. Nimkar’s clinical and research interests include benign breast disease, breast conservation surgery, mastectomy with immediate reconstruction, nipple-sparing mastectomy, pregnancy-associated breast cancer and sentinel lymph node biopsy. Dr. Nimbkar is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Lymphadenectomy, and Mastectomy.

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

Shail Maingi is a Hematologist Oncology specialist and a Palliative Medicine provider in South Weymouth, Massachusetts. Dr. Maingi is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer in Men. Dr. Maingi is currently accepting new patients.

Barbara Civiello is an Oncologist and a Hematologist in South Weymouth, Massachusetts. Dr. Civiello is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer.

Ewa Niemierko is a Hematologist Oncology specialist and a Hematologist in South Weymouth, Massachusetts. Dr. Niemierko is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Niemierko is currently accepting new patients.

Michael Cassidy is a Surgical Oncologist and a General Surgeon in Boston, Massachusetts. Dr. Cassidy has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Angiosarcoma, Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Cassidy is currently accepting new patients.

Beth Overmoyer is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Overmoyer is rated as an Elite provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Meredith Faggen is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Faggen is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer. Dr. Faggen is currently accepting new patients.

Jonathan Opraseuth is an Interventional Radiologist in South Weymouth, Massachusetts. Dr. Opraseuth has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Pleurisy, Ascites, Pleural Effusion, Bone Graft, and Vertebroplasty.

Laura Miller is a Radiologist in South Weymouth, Massachusetts. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Lump, Pleurisy, Ascites, and Pleural Effusion.

Prabhsimranjot Singh is an Oncologist in South Weymouth, Massachusetts. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Ursula Matulonis is an Oncologist in South Weymouth, Massachusetts. Dr. Matulonis is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Tubal Ligation.

Christopher Vetter is a Surgical Oncologist and a General Surgeon in South Weymouth, Massachusetts. Dr. Vetter is rated as an Experienced provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Gallbladder Disease, Hernia, Choledocholithiasis, Hernia Surgery, and Mastectomy.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, HER-2 Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Rochelle Scheib is an Oncologist in Boston, Massachusetts. Dr. Scheib is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.